首页> 外文期刊>Clinical ophthalmology >Intersession test—retest variability of conventional and novel parameters using the MP-1 microperimeter
【24h】

Intersession test—retest variability of conventional and novel parameters using the MP-1 microperimeter

机译:会话间测试-使用MP-1微型视野仪重新测试常规参数和新参数的变异性

获取原文
           

摘要

Purpose: To investigate the intersession test–retest variability (TRV) of topography- and threshold-based parameters derived from the Nidek MP-1. Design: Prospective observational study. Methods: Sixteen participants with and without central scotoma underwent microperimetry in one eye over three sessions at 1-month intervals in a single institution. We calculated 95% coefficient of repeatability (CR) for the number of normal-suspect (NS) loci, relative scotoma (RS) and dense scotoma (DS), median macular sensitivity (MS), mean sensitivity of responding loci (RLS), perilesional loci (PLS), and extralesional loci (ELS). Topographical agreement score of mapping NS and DS loci (TASNS and TASDS) were also calculated for each patient. Results: Mean (range) age was 50 (21–86) years. The CR (95% confidence intervals) for NS, RS, and DS were 9.9 (6.5–13.3), 9.5 (6.2–12.7), and 3.0 (1.1–4.1) respectively. CR (95% CIs) for median MS, mean RLS, PLS, and ELS were 3.4 (2.3–4.5), 1.6 (1.1–2.2), 1.8 (0.9–2.6), and 2.8 (1.5–4.0) dB. We found significant change in thresholds between Test 1, and Tests 2 and 3 (both P =0.03), but not between Tests 2 and 3 ( P =0.8). Medians (range) TASNS and TASDS were 74% (39%–100%) and 77% (0%–97%), respectively, between Tests 2 and 3. Conclusion: We recommend the use of four DS loci (upper limit of CR) as the limit of TRV for assessing change. There was large interindividual variability in NS or DS mapping agreement. We recommend discarding the first microperimetry test and caution the use of a change in spatial distribution to determine disease progression.
机译:目的:研究从Nidek MP-1派生的基于地形和基于阈值的参数的会话间重测变异性(TRV)。设计:前瞻性观察研究。方法:在单个机构中,以1个月的间隔在三个疗程中对16名有和没有中枢性阴囊肿的参与者进行一只眼的微视野测量。我们计算了正常可疑(NS)位点,相对性真核细胞(RS)和致密性真核细胞(DS),中位黄斑敏感性(MS),响应基因座的平均敏感性(RLS)的数目的95%重复性系数(CR),病灶周围位点(PLS)和病灶外位点(ELS)。还为每位患者计算了映射NS和DS基因座的拓扑一致性得分(TAS NS 和TAS DS )。结果:平均(范围)年龄为50(21-86)岁。 NS,RS和DS的CR(95%置信区间)分别为9.9(6.5-13.3),9.5(6.2-12.7)和3.0(1.1-4.1)。中位MS,平均RLS,PLS和ELS的CR(95%CI)为3.4(2.3-4.5),1.6(1.1-2.2),1.8(0.9-2.6)和2.8(1.5-4.0)dB。我们发现在测试1,测试2和3之间的阈值有显着变化(均为P = 0.03),而在测试2和3之间(P = 0.8)没有变化。在测试2和测试2之间,TAS NS 和TAS DS 的中位数(范围)分别为74%(39%–100%)和77%(0%–97%)。 3.结论:我们建议使用四个DS位点(CR的上限)作为TRV的限制来评估变化。 NS或DS映射协议之间存在较大的个体差异。我们建议您放弃第一个微视野检查法,并提醒您使用空间分布的变化来确定疾病的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号